Scientists gathered to discuss the future of synthetic biology and how it can help curb climate change and promote sustainability.
Nobelists credit basic research
A two-day event at the Stanford School of Medicine brought together investors, regulators, company executives and scientists to discuss the most productive ways for them to work together.
Skin-colonizing bacteria help fight tumors
In a study led by Stanford Medicine, researchers harnessed the skin’s immune response to bacteria to create an immunotherapy — delivered by swab — that treats aggressive tumors in mice.
Nobelist Paul Berg dies
Credited with sparking the field of genetic engineering, Stanford Medicine biochemist Paul Berg shared the 1980 Nobel Prize in chemistry for creating the first recombinant DNA molecule.
Bioethicists support researchers
In the five decades since the emergence of recombinant DNA technology, researchers at Stanford Medicine have benefited from the close involvement of bioethics experts.
Bertozzi research advances medicine
Bertozzi’s chemistry expertise advances research into cancer immunotherapies, tumor biology and COVID-19.
Deisseroth to receive Horwitz Prize
The Stanford psychiatrist, neuroscientist and engineer is honored for developing a technology that lets researchers pinpoint the functions — and malfunctions — of specific brain circuits.
‘Digital human’ helps reduce knee stress
A computer simulation that relates muscle activation patterns to harmful pressure on the knee helps participants adopt knee-protective strategies as they walk.
Implants, natural eyesight coordinate
A Stanford scientist and his colleagues show that patients fitted with a chip in their eye are able to integrate what the chip “sees” with objects their natural peripheral vision detects.
Stanford Biodesign turns 20
A training program for health technology innovators, the center has generated medical technologies that have helped millions of patients and inspired similar training programs worldwide.
Karl Deisseroth wins Lasker award
Discoveries by Deisseroth and his two co-recipients regarding microbial light-activated molecules led to his development of a way to manipulate selected neurons in living animals to observe changes in their behavior.
Study reveals immune therapy’s challenge
CAR-T cell therapy works for many types of blood cancers, but more than half of patients relapse. A Stanford study provides a clue as to why.
- Aging & Geriatrics
- AI, Technology & Innovation
- Anesthesiology & Pain Management
- Animal Research
- Autoimmune Conditions
- Blood Disorders (Hematology)
- Cellular & Molecular Biology
- Community Programs
- Data Sciences
- Diversity, Equity & Inclusion
- Drug Development
- Ear, Nose & Throat
- Emergency Medicine
- Environment & Sustainability
- Epidemiology & Population Health
- Global Health
- Health Policy
- Infectious Disease
- Internal Medicine
- Kidney Health (Nephrology)
- Lung Health
- Maternal Health
- Men's Health
- Neurology & Neurosurgery
- Obstetrics & Gynecology
- Palliative Care
- Precision Health
- Preventive Medicine
- Primary Care
- Psychiatry & Mental Health
- Stanford Medicine
- Stem Cells
- Women's Health